- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/22 - Hormones
Patent holdings for IPC class A61K 38/22
Total number of patents in this class: 2651
10-year publication summary
|
243
|
233
|
215
|
218
|
176
|
187
|
177
|
146
|
147
|
75
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
82 |
| Novo Nordisk A/S | 2287 |
47 |
| Mayo Foundation for Medical Education and Research | 3188 |
34 |
| Eli Lilly and Company | 3814 |
33 |
| Hanmi Pharm. Co., Ltd. | 569 |
33 |
| MannKind Corporation | 524 |
31 |
| BioMarin Pharmaceutical Inc. | 378 |
28 |
| Rani Therapeutics, LLC | 197 |
28 |
| Zealand Pharma A/S | 250 |
27 |
| Ascendis Pharma Growth Disorders A/S | 54 |
26 |
| The Regents of the University of California | 19812 |
25 |
| The Board of Trustees of the Leland Stanford Junior University | 6365 |
25 |
| Transdermal Biotechnology, Inc. | 76 |
24 |
| Adocia | 141 |
23 |
| Janssen Pharmaceutica N.V. | 3423 |
22 |
| Sanofi | 4009 |
20 |
| University of Florida Research Foundation, Inc. | 3989 |
18 |
| University of Miyazaki | 135 |
18 |
| The General Hospital Corporation | 4704 |
17 |
| Duke University | 3058 |
17 |
| Other owners | 2073 |